Bangladesh Reverts Vaccine Procurement to UNICEF Amid Measles Crisis

    After facing a severe measles outbreak, Bangladesh's interim government reinstates UNICEF for vaccine procurement. This change highlights the risks of altering established supply chains during health emergencies and underscores the need for timely decision-making to mitigate public health crises.

    United Nations Children's Fund, Government of Bangladesh, Directorate General of Health Services, World Health Organization, Gavi, the Vaccine Alliance

    Key Signals

    • Bangladesh reinstates UNICEF for vaccine supply amidst severe measles outbreak.
    • Over 32,000 suspected measles cases reported in Bangladesh after procurement shift.
    • Emergency vaccination campaigns launched in response to public health crisis.

    "The loss of children to a fully preventable disease like measles is heartbreaking. It is a human tragedy, and my deepest condolences go to every family that has suffered."

    Prof Sayedur Rahman, Health Adviser, Interim Government of Bangladesh

    The ongoing measles epidemic in Bangladesh has underscored the critical importance of reliable vaccine procurement channels in public health emergencies. In September 2025, the interim government took the controversial step of shifting measles-rubella vaccine procurement from the United Nations Children’s Fund (UNICEF), an entity known for its established supply chain in healthcare, to an open tender system. This decision was made despite explicit warnings from UNICEF regarding potential delays that could result from such a change. This procurement switch coincided with an alarming rise in measles infections across the country, resulting in over 32,000 suspected cases and more than 250 fatalities, primarily among children. As reported by the World Health Organization (WHO), the situation escalated quickly since the onset of the outbreak in January, particularly spreading from the Rohingya refugee camps in southeastern Bangladesh. By the end of March 2026, a staggering 59% of eligible children had not received the measles vaccine, severely hampering the national immunization campaign.

    The interim government's move to an open tender was heavily criticized by health experts and organizations such as UNICEF, which argued that it would delay crucial vaccine supplies, thereby exacerbating the public health crisis. UNICEF’s representative to Bangladesh, Rana Flowers, articulated her frustration at the decision, recalling her pleas to the health adviser, Nurjahan Begum, not to pursue this option. The delays were compounded by bureaucratic hurdles involved in the tendering process, leading to significant shortages of vaccines necessary for immunizing the population. These interruptions in routine immunization not only risked further outbreaks but ultimately led to a loss of confidence in the government’s ability to manage such public health emergencies.

    In April 2026, the dire circumstances prompted the government to reinstate the procurement channels with UNICEF and initiate emergency vaccination campaigns aimed at controlling the measles outbreak. This shift reflects a critical understanding that relying on established supply chains with experienced international suppliers is vital during periods of health crisis. The decision to revert back emphasizes the precarious balance required between cost-saving measures in procurement and the urgent need to ensure supply continuity when public health is at stake. The collaboration with organizations such as Gavi, the Vaccine Alliance, and the Directorate General of Health Services in Bangladesh demonstrates a multifaceted effort to restore immunization coverage quickly.

    Procurement professionals and contractors involved in public health should take heed of the lessons learned from this situation to mitigate future risks associated with changing vaccine supply chains, particularly amid crises. The fallout from this outbreak serves as a sobering reminder that timely procurement decisions are imperative for preventing severe public health issues. As Bangladesh and similar countries face the ongoing challenge of ensuring public health safety, there is a growing demand for solid partnerships and reliable supply channels to support immunization efforts in vulnerable populations. Outsourcing procurement during times of crisis to entities unproven in emergency logistics can yield dire results, highlighting the necessity of established relationships in global health response.

    • The interim government's September 2025 shift to open tender delayed vaccine availability, highlighting procurement risks in emergency health programs.
    • Reinstatement of UNICEF procurement in April 2026 underscores reliance on experienced international suppliers for critical vaccines.
    • Procurement officials should evaluate the impact of tendering processes on supply continuity and outbreak control.
    • Vaccine manufacturers and suppliers may find opportunities in emergency procurement and immunization campaign support in Bangladesh and similar contexts.
    • Over 32,000 suspected measles cases and more than 250 deaths primarily among children illustrate the potential crisis impact of procurement missteps.
    • The decision to revert back to UNICEF procurement underscores the importance of timely and effective public health decision-making.

    Agencies

    • United Nations Children's Fund
    • Government of Bangladesh
    • Directorate General of Health Services
    • World Health Organization
    • Gavi, the Vaccine Alliance